LabConnect Appoints Industry Veteran Bill Finger to Lead Global Strategic Services
LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, bringing over 25 years of diagnostics and clinical research expertise to enhance the company's capabilities in complex clinical trials.
LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, effective September 10, 2025. Finger brings more than 25 years of diagnostics and clinical research experience to the role, with deep expertise in the global lab and pharmacy industry. He is recognized as an innovative thinker with proven ability to develop strategy, drive execution, and advance organizational performance while maintaining focus on operational excellence.
In his new position, Finger will lead LabConnect's Scientific Services, Consulting Services, Data Management, and Functional Service Provider teams. His appointment signals LabConnect's commitment to strengthening its leadership in complex clinical trial support services. The company specializes in central laboratory services for analytically and logistically complex studies including immuno-oncology, cell and gene therapies, and rare & orphan diseases.
Finger's most recent role was as Vice President and General Manager of Pharma Services with Quest Diagnostics. His extensive background includes serving as Chief Operating Officer for Interpace Pharma Solutions and Executive Vice President of Precision Medicine and Pharma for Cancer Genetics. He also held leadership roles in scientific affairs and biorepository with LabCorp, giving him comprehensive experience across major laboratory service providers.
LabConnect CEO Wes Wheeler emphasized the significance of this appointment, stating that Finger's leadership in diagnostic and clinical research represents a tremendous asset to the company. Wheeler noted that Finger's experience will help LabConnect continue to anticipate client needs, deliver innovative solutions, and reinforce commitment to operational excellence for clients worldwide. For more information about LabConnect's services, visit https://www.labconnect.com.
The appointment comes as the pharmaceutical and biotechnology industries increasingly rely on specialized central laboratory services for complex clinical trials. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, and extensive specialized testing expertise positions the company to meet growing demand from drug development companies requiring comprehensive central laboratory service solutions.